Valuation : Novartis AG

Market Cap 30TCr 26TCr 24TCr 22TCr 42TCr 28,62000Cr 42TCr 2,86100Cr 1,10900Cr 14,43800Cr 1,12700Cr 1,10200Cr 47,82200Cr P/E 2026 *
22.4x
P/E 2027 * 19.1x
Enterprise Value 33TCr 29TCr 27TCr 24TCr 46TCr 31,73700Cr 46TCr 3,17200Cr 1,22900Cr 16,01100Cr 1,24900Cr 1,22200Cr 53,03000Cr EV / Sales 2026 *
5.77x
EV / Sales 2027 * 5.35x
Free-Float
91.66%
Yield 2026 *
2.77%
Yield 2027 * 2.89%
1 day-1.13%
1 week-1.73%
Current month+0.89%
1 month+1.63%
3 months+4.47%
6 months-4.82%
Current year+14.27%
1 week 156.1
Extreme 156.1
160.29
1 month 149.09
Extreme 149.09
160.81
Current year 135.55
Extreme 135.55
170.46
1 year 121.57
Extreme 121.57
170.46
3 years 92.19
Extreme 92.19
170.46
5 years 74.09
Extreme 74.09
170.46
10 years 66.93
Extreme 66.93
170.46
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Compliance Officer 58 14/04/2025
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Change 5-day change 1-year change 3-year change Capi.($)
-1.53%-1.73% - - 30TCr
-3.59%-7.10%+61.60%+114.83% 1,06000Cr
-1.15%-1.25%+52.98%+62.41% 65TCr
-1.09%-1.15%+26.18%+79.22% 46TCr
-0.76%-1.75%+39.11%+40.96% 37TCr
-0.74%-0.09%+23.77%+39.53% 30TCr
-0.19%+1.53%+3.05%+13.24% 26TCr
-0.43%-0.46%+52.06%+71.75% 24TCr
-1.55%+1.84%-13.11%-52.28% 21TCr
-0.46%+0.33%+29.05%+92.67% 18TCr
Average -1.10%-0.66%+30.52%+51.37% 41.45TCr
Weighted average by Cap. -1.60%-2.16%+39.97%+67.68%

Financials

2026 *2027 *
Net sales 5.76TCr 4.95TCr 4.64TCr 4.24TCr 8.01TCr 5,49800Cr 8.04TCr 55TCr 21TCr 2,77400Cr 22TCr 21TCr 9,18800Cr 6.13TCr 5.26TCr 4.94TCr 4.51TCr 8.51TCr 5,84800Cr 8.55TCr 58TCr 23TCr 2,95000Cr 23TCr 23TCr 9,77100Cr
Net income 1.4TCr 1.2TCr 1.12TCr 1.03TCr 1.94TCr 1,33100Cr 1.95TCr 13TCr 5.15TCr 67TCr 5.24TCr 5.12TCr 2,22300Cr 1.55TCr 1.33TCr 1.25TCr 1.14TCr 2.15TCr 1,47900Cr 2.16TCr 15TCr 5.73TCr 75TCr 5.82TCr 5.69TCr 2,47100Cr
Net Debt 3.27TCr 2.8TCr 2.63TCr 2.4TCr 4.54TCr 3,11700Cr 4.56TCr 31TCr 12TCr 1,57200Cr 12TCr 12TCr 5,20800Cr 2.78TCr 2.39TCr 2.24TCr 2.05TCr 3.86TCr 2,65300Cr 3.88TCr 27TCr 10TCr 1,33900Cr 10TCr 10TCr 4,43300Cr
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
26/26/26 $157.54 -1.53% 14,73,550
25/26/25 $159.98 +1.24% 9,98,182
24/26/24 $158.02 -0.53% 8,01,260
21/26/21 $158.86 +1.68% 11,83,728
20/26/20 $156.24 -2.54% 15,25,742
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
157.87USD
Average target price
154.32USD
Spread / Average Target
-2.25%

Quarterly revenue - Rate of surprise